Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.

[1]  D. Morrow.  New insight into clinical risk scores for patients with acute coronary syndromes. , 2003, American heart journal.

[2]  C. Cannon.  Evidence-based risk stratification to target therapies in acute coronary syndromes. , 2002, Circulation.

[3]  S. Yusuf,et al.  Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups , 2002, Circulation.

[4]  E. Antman,et al.  Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. , 2002, The American journal of cardiology.

[5]  René M. Botnar,et al.  Age and Sex Distribution of Subclinical Aortic Atherosclerosis: A Magnetic Resonance Imaging Examination of the Framingham Heart Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[6]  E. Antman,et al.  An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. , 2002, European heart journal.

[7]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[8]  E. Antman,et al.  Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. , 2001, American heart journal.

[9]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[10]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[11]  S. Snapinn,et al.  Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s , 1999, Circulation.

[12]  C. Heeschen,et al.  Angiographic findings in patients with refractory unstable angina according to troponin T status. , 1999, Circulation.

[13]  E. Vicaut,et al.  Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. , 1999, American heart journal.

[14]  R. Califf,et al.  Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. , 1999, The American journal of cardiology.

[15]  R. Califf,et al.  Prognostic value of the admission electrocardiogram in acute coronary syndromes. , 1999, JAMA.

[16]  S Wallenstein,et al.  Correlation of angiographic morphology and clinical presentation in unstable angina. , 1997, Journal of the American College of Cardiology.

[17]  R. Virmani,et al.  Effect of age, race, body surface area, heart weight and atherosclerosis on coronary artery dimensions in young males. , 1996, Atherosclerosis.

[18]  V. Froelicher,et al.  Correlation between resting ST segment depression, exercise testing, coronary angiography, and long-term prognosis. , 1991, American heart journal.

[19]  V. Fuster,et al.  Usefulness of ST-segment changes in ≥2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome , 1991 .